Key result
Adrenergic signaling drives hypertension via β2-AdR methylation and NK/ILC activation in lymphocyte-deficient hosts.
Why the study?
T cells contribute to hypertension, but hypertension also occurs in settings of T cell deficiency.
Does beta 2 adrenergic receptor gene methylation and NK/ILC activation drive hypertension in lymphocyte-deficient hosts?
Does beta 2 adrenergic receptor gene methylation and NK/ILC activation drive hypertension in lymphocyte-deficient hosts?
Modulation of NK/ILCs activation by adrenergic signaling governs an escape mechanism enabling the development of hypertension in lymphocyte-deficient hosts.
Should not alter hypertension management; leaves open whether β2-AdR methylation drives NK/ILC hypertension in humans.
AIMS: T cells contribute to hypertension; however, hypertension occurs in settings of T cell deficiency. METHODS AND RESULTS: We studied two colonies of T/B cell-deficient RAG-1-/- mice with disparate responses to angiotensin II, being one protected from blood pressure increase and the other one responsive. This difference depends on the capability of hypertensive RAG-1-/- mice to expand natural killer and innate lymphoid cells (NK/ILCs) that produce pro-hypertensive cytokines. This process is regulated by the DNA methylation status of the β2 adrenergic receptor (β2-AdR). Angiotensin II caused blood pressure elevation in T and NK/ILCs-deficient mice only when either T or NK/ILCs cells were adoptively reconstituted. Additional studies showed NK cell expansion in humans that underwent B cell depletion, and this was augmented in those with hypertension. CONCLUSIONS: These findings illustrate that the modulation of NK/ILCs activation by adrenergic signalling governs an escape mechanism in lymphocyte-deficient host, enabling the development of hypertension.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2025) studied Hypertension. Angiotensin II was evaluated on Blood pressure elevation and NK cell expansion. Modulation of NK/ILCs activation by adrenergic signaling, regulated by β2-AdR DNA methylation, enables the development of hypertension in lymphocyte-deficient hosts.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: